Raymond James Financial Inc. cut its holdings in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,237 shares of the medical instruments supplier's stock after selling 236 shares during the quarter. Raymond James Financial Inc.'s holdings in Mettler-Toledo International were worth $8,546,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the company. Greenleaf Trust raised its holdings in Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after purchasing an additional 10 shares in the last quarter. Albion Financial Group UT raised its holdings in Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after purchasing an additional 11 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in Mettler-Toledo International by 1.8% in the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after purchasing an additional 11 shares in the last quarter. TD Private Client Wealth LLC raised its holdings in Mettler-Toledo International by 5.4% in the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock worth $253,000 after purchasing an additional 11 shares in the last quarter. Finally, Congress Asset Management Co. raised its holdings in Mettler-Toledo International by 1.8% in the first quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier's stock worth $788,000 after purchasing an additional 12 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.
Mettler-Toledo International Price Performance
Shares of NYSE:MTD traded down $8.83 during midday trading on Wednesday, reaching $1,267.17. 109,383 shares of the company's stock were exchanged, compared to its average volume of 133,079. The firm's 50 day simple moving average is $1,246.95 and its two-hundred day simple moving average is $1,186.57. The stock has a market cap of $26.10 billion, a price-to-earnings ratio of 32.09, a P/E/G ratio of 3.90 and a beta of 1.37. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company's quarterly revenue was up 3.9% on a year-over-year basis. During the same period last year, the company earned $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the stock. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their price objective for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Citigroup raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Bank of America increased their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research report on Thursday, June 26th. Robert W. Baird increased their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research report on Monday, August 4th. Finally, Barclays assumed coverage on Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective on the stock. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $1,311.11.
Read Our Latest Research Report on MTD
Insider Buying and Selling at Mettler-Toledo International
In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares of the company's stock, valued at $6,389,588.55. The trade was a 5.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total value of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares of the company's stock, valued at approximately $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock valued at $2,371,208 in the last three months. 0.77% of the stock is owned by corporate insiders.
Mettler-Toledo International Company Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Read More

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report